Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,000 | $634.82 | $1,269,634.00 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,557,854 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.145 to $635.12, inclusive. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 802 | $633.52 | $508,079.03 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,559,854 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.075 to $633.9375, inclusive. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,098 | $632.17 | $5,751,491.76 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,560,656 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.00 to $632.36, inclusive. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,503 | $631.38 | $13,576,521.13 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,569,754 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.00 to $631.9875, inclusive. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 128,627 | $630.19 | $81,059,449.13 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,591,257 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6) and (7) to this Form 4. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,491 | $633.41 | $2,211,234.31 |
DisclosureSEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,719,884 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.20 to $633.745, inclusive. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,566 | $632.52 | $9,213,300.89 |
DisclosureSEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,723,375 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.18 to $633.125, inclusive. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,608 | $631.72 | $3,542,657.72 |
DisclosureSEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,737,941 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.155 to $632.15, inclusive. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,873 | $630.39 | $6,854,219.60 |
DisclosureSEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,743,549 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 19:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 700 | $631.07 | $441,747.60 |
DisclosureSEC source: 0001415889-24-000758 · form4-01052024_070143.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,754,422 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.035 to $631.145, inclusive. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 19:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 13,688 | $630.24 | $8,626,697.74 |
DisclosureSEC source: 0001415889-24-000758 · form4-01052024_070143.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,755,122 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:08 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 20 | $579.76 | $11,595.20 |
DisclosureSEC source: 0000059478-23-000318 · wk-form4_1703020095.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,872 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:10 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 17 | $579.76 | $9,855.92 |
DisclosureSEC source: 0000059478-23-000320 · wk-form4_1703020205.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,886 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:12 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 17 | $579.76 | $9,855.92 |
DisclosureSEC source: 0000059478-23-000322 · wk-form4_1703020305.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:13 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 17 | $579.76 | $9,855.92 |
DisclosureSEC source: 0000059478-23-000324 · wk-form4_1703020406.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,569 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:15 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 25 | $579.76 | $14,494.00 |
DisclosureSEC source: 0000059478-23-000326 · wk-form4_1703020494.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,569 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:16 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 9 | $579.76 | $5,217.84 |
DisclosureSEC source: 0000059478-23-000328 · wk-form4_1703020592.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,069 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · derivative · entry 4 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,810 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
Tax withholdingCommon Stock | 2,142 | $591.04 | $1,266,007.68 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · nonDerivative · entry 2 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,376 Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
Exercise / conversionCommon Stock | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000316 · wk-form4_1701724633.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:14 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000294 · wk-form4_1700601227.xml · nonDerivative · entry 2 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,751 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:14 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 19 | $597.60 | $11,354.40 |
DisclosureSEC source: 0000059478-23-000294 · wk-form4_1700601227.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,416 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:15 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000296 · wk-form4_1700601310.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,667 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:18 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000298 · wk-form4_1700601516.xml · nonDerivative · entry 2 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,736 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:18 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 17 | $597.60 | $10,159.20 |
DisclosureSEC source: 0000059478-23-000298 · wk-form4_1700601516.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,401 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:20 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000300 · wk-form4_1700601640.xml · nonDerivative · entry 2 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:20 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 17 | $597.60 | $10,159.20 |
DisclosureSEC source: 0000059478-23-000300 · wk-form4_1700601640.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,068 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:22 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000302 · wk-form4_1700601755.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,794 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:26 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000306 · wk-form4_1700601953.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,026 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:24 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000304 · wk-form4_1700601853.xml · nonDerivative · entry 2 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,548 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:24 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 16 | $597.60 | $9,561.60 |
DisclosureSEC source: 0000059478-23-000304 · wk-form4_1700601853.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,213 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:27 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000308 · wk-form4_1700602048.xml · nonDerivative · entry 2 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,515 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:27 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 24 | $597.60 | $14,342.40 |
DisclosureSEC source: 0000059478-23-000308 · wk-form4_1700602048.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,180 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000310 · wk-form4_1700602131.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,593 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000312 · wk-form4_1700602226.xml · nonDerivative · entry 2 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,057 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 8 | $597.60 | $4,780.80 |
DisclosureSEC source: 0000059478-23-000312 · wk-form4_1700602226.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,722 F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:31 UTC |
Walker KarenDirector
|
GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000314 · wk-form4_1700602310.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,909 Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 21:16 UTC |
Ricks David ADirector · President, Chair, and CEO
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000292 · wk-form4_1700082977.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 425,443 Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 21:19 UTC |
Skovronsky DanielEVP, CS&MO & Pres., LRL
|
GiftCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000290 · wk-form4_1699910380.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · EVP, CS&MO & Pres., LRL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,321 Read SEC document |
| November 06, 2023 Filed Nov 6, 2023 21:25 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
SaleCommon Stock | 670 | $571.10 | $382,637.00 |
DisclosureSEC source: 0000059478-23-000286 · wk-form4_1699305940.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,708 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:15 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 18 | $616.64 | $11,099.52 |
DisclosureSEC source: 0000059478-23-000266 · wk-form4_1697573710.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,397 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:18 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 16 | $616.64 | $9,866.24 |
DisclosureSEC source: 0000059478-23-000268 · wk-form4_1697573880.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,384 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:19 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 16 | $616.64 | $9,866.24 |
DisclosureSEC source: 0000059478-23-000270 · wk-form4_1697573978.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,051 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:21 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 16 | $616.64 | $9,866.24 |
DisclosureSEC source: 0000059478-23-000272 · wk-form4_1697574065.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,197 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:22 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 23 | $616.64 | $14,182.72 |
DisclosureSEC source: 0000059478-23-000274 · wk-form4_1697574169.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,156 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:24 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 8 | $616.64 | $4,933.12 |
DisclosureSEC source: 0000059478-23-000276 · wk-form4_1697574262.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,714 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,122 | $607.74 | $12,836,747.65 |
DisclosureSEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,768,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.3698 to $608.20, inclusive. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 51,998 | $606.75 | $31,549,630.51 |
DisclosureSEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,789,932 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.31 to $607.27, inclusive. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 74,203 | $605.41 | $44,923,386.64 |
DisclosureSEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,841,930 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.27 to $606.1522, inclusive. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 20:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,842 | $604.40 | $18,036,415.27 |
DisclosureSEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,916,133 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $604.00 to $604.94, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.